Per ulteriori informazioni selezionare i riferimenti di interesse.
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
JOURNAL OF CLINICAL ONCOLOGY
Clinical relevance of single item quality of life indicators in cancer clinical trials
BRITISH JOURNAL OF CANCER
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
JOURNAL OF CLINICAL ONCOLOGY
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
JOURNAL OF CLINICAL ONCOLOGY
Identifying breast cancer patients at high risk for bone metastases
JOURNAL OF CLINICAL ONCOLOGY
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
LANCET
Efficacy of pamidronate in breast cancer with bone metastases: A randomized, double-blind placebo-controlled multicenter study
ANTICANCER RESEARCH
PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
European journal of cancer
DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER
European journal of cancer
THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE
European journal of cancer
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Lancet
THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY
Cancer
FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS
British Journal of Cancer
RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY
European journal of cancer
QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH
Annals of oncology
MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Annals of oncology
PROGNOSTIC IMPORTANCE OF THYMIDYLATE SYNTHASE EXPRESSION IN EARLY BREAST-CANCER
Journal of clinical oncology
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Journal of clinical oncology
THE GOTHENBURG BREAST SCREENING TRIAL - FIRST RESULTS ON MORTALITY, INCIDENCE, AND MADE OF DETECTION FOR WOMEN AGES 39-49 YEARS AT RANDOMIZATION
Cancer
THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER
Annals of oncology
OPEN TRIALS IN CUTANEOUS MALIGNANT-MELANOMA
European journal of surgical oncology
OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS
Lancet
IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER
Lancet
RESPONSIVENESS OF A SINGLE-ITEM INDICATOR VERSUS A MULTIITEM SCALE - ASSESSMENT OF EMOTIONAL WELL-BEING IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL
Medical care
DACARBAZINE-VINDESINE VS DACARBAZINE-VINDESINE-CISPLATINUM IN DISSEMINATED MELANOMA - A RANDOMIZED PHASE-III TRIAL
European journal of cancer
ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER
Annals of oncology
EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
The New England journal of medicine
THE BEST AVAILABLE ADJUVANT TREATMENTS ARE WITHIN THE FRAMEWORK OF CLINICAL-TRIALS - THE INTERNATIONAL BREAST-CANCER STUDY-GROUP
Israel journal of medical sciences
WHOLE-BODY ENERGY-EXPENDITURE PROTEIN BREAKDOWN AND POLYAMINE EXCRETION DURING HIGH-DOSE TREATMENT WITH INTERLEUKIN-2 AND INTERFERON-ALPHA
The European journal of surgery
THE INTERNATIONAL (LUDWIG) BREAST-CANCER STUDY-GROUP TRIALS I-IV - 15YEARS FOLLOW-UP
Annals of oncology
TIMING OF BASE-LINE QUALITY-OF-LIFE ASSESSMENT IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL - ITS EFFECT ON PATIENT SELF-ESTIMATION
Annals of oncology
HISTAMINE IN IMMUNOTHERAPY OF ADVANCED MELANOMA - A PILOT-STUDY
Cancer immunology and immunotherapy
EFFECT OF SYSTEMIC ADJUVANT TREATMENT ON FIRST SITES OF BREAST-CANCERRELAPSE
Lancet
PRESENT AND FUTURE PROJECTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP
Cancer
PROGNOSTIC VALUE OF HELIX-POMATIA IN BREAST-CANCER
British Journal of Cancer